Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents.
暂无分享,去创建一个
Wen Xie | Tao Sheng | Duan Liu | M. Gallo | P. Thomas | A. Rabson | W. Xie | Yanan Tian | Xinsheng Gu | Arnold B Rabson | Yanan Tian | Michael A Gallo | Xinsheng Gu | Sui Ke | Duan Liu | Paul E Thomas | S. Ke | Tao Sheng
[1] J. Lehmann,et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. , 1998, The Journal of clinical investigation.
[2] Ning Li,et al. Role of liver-enriched transcription factors in the down-regulation of organic anion transporting polypeptide 4 (oatp4; oatplb2; slc21a10) by lipopolysaccharide. , 2004, Molecular pharmacology.
[3] M. Gallo,et al. Mechanism of Suppression of Cytochrome P-450 1A1 Expression by Tumor Necrosis Factor-α and Lipopolysaccharide* , 2001, The Journal of Biological Chemistry.
[4] B. Goodwin,et al. The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module. , 1999, Molecular pharmacology.
[5] S. Safe,et al. Reciprocal Activation of Xenobiotic Response Genes by Nuclear Receptors Sxr/pxr and Car , 2000 .
[6] T. A. Richardson,et al. Hepatic Cytochrome P450 Gene Regulation during Endotoxin-Induced Inflammation in Nuclear Receptor Knockout Mice , 2005, Journal of Pharmacology and Experimental Therapeutics.
[7] C. Martinez-Jimenez,et al. Transcriptional Regulation of the Human Hepatic CYP3A4: Identification of a New Distal Enhancer Region Responsive to CCAAT/Enhancer-Binding Protein β Isoforms (Liver Activating Protein and Liver Inhibitory Protein) , 2005, Molecular Pharmacology.
[8] A. Arsenault,et al. Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation. , 2005, American journal of physiology. Gastrointestinal and liver physiology.
[9] P. Guzelian,et al. Cyp3A regulation: from pharmacology to nuclear receptors. , 2001, Drug metabolism and disposition: the biological fate of chemicals.
[10] M. Gallo,et al. Ah receptor and NF-κB interactions: mechanisms and physiological implications , 2002 .
[11] K. Feingold,et al. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. , 2002, Biochemical and biophysical research communications.
[12] T. Sueyoshi,et al. Drug-activated nuclear receptors CAR and PXR , 2003, Annals of medicine.
[13] G. Trinchieri,et al. Retinoids Inhibit Interleukin-12 Production in Macrophages through Physical Associations of Retinoid X Receptor and NFκB* , 1999, The Journal of Biological Chemistry.
[14] O. Hankinson,et al. Recruitment of the NCoA/SRC-1/p160 Family of Transcriptional Coactivators by the Aryl Hydrocarbon Receptor/Aryl Hydrocarbon Receptor Nuclear Translocator Complex , 2002, Molecular and Cellular Biology.
[15] Paul T Tarr,et al. Regulation of Multidrug Resistance-associated Protein 2 (ABCC2) by the Nuclear Receptors Pregnane X Receptor, Farnesoid X-activated Receptor, and Constitutive Androstane Receptor* , 2002, The Journal of Biological Chemistry.
[16] Yanan Tian,et al. Interactions between the Aryl Hydrocarbon Receptor and P-TEFb , 2003, Journal of Biological Chemistry.
[17] R Ohlsson,et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Lehmann,et al. An Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway , 1998, Cell.
[19] Bruno Stieger,et al. Enterohepatic bile salt transporters in normal physiology and liver disease. , 2004, Gastroenterology.
[20] E. Morgan. Regulation of cytochromes P450 during inflammation and infection. , 1997, Drug metabolism reviews.
[21] Michael Karin,et al. NF-κB: linking inflammation and immunity to cancer development and progression , 2005, Nature Reviews Immunology.
[22] C. Handschin,et al. Induction of Drug Metabolism: The Role of Nuclear Receptors , 2003, Pharmacological Reviews.
[23] F. Guengerich,et al. Cytochrome P-450 3A4: regulation and role in drug metabolism. , 1999, Annual review of pharmacology and toxicology.
[24] B. M. Forman,et al. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.
[25] M. Pirovino,et al. Preserved cytosolic and synthetic liver function in jaundice of severe extrahepatic infection. , 1989, Gastroenterology.
[26] C. Klaassen,et al. Induction of rat organic anion transporting polypeptide 2 by pregnenolone-16alpha-carbonitrile is via interaction with pregnane X receptor. , 2002, Molecular pharmacology.
[27] John T. Moore,et al. CAR: detailing new models. , 2004, Trends in pharmacological sciences.
[28] O. Hankinson,et al. Functional Involvement of the Brahma/SWI2-related Gene 1 Protein in Cytochrome P4501A1 Transcription Mediated by the Aryl Hydrocarbon Receptor Complex* , 2002, The Journal of Biological Chemistry.
[29] Cathy H. Wu,et al. The Universal Protein Resource (UniProt) , 2004, Nucleic Acids Res..
[30] W. Sabbagh,et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. , 1998, Genes & development.
[31] M. Gallo,et al. Ah Receptor and NF-κB Interactions, a Potential Mechanism for Dioxin Toxicity* , 1999, The Journal of Biological Chemistry.
[32] K. Goralski,et al. THE SIGNAL TRANSDUCTION PATHWAYS INVOLVED IN HEPATIC CYTOCHROME P450 REGULATION IN THE RAT DURING A LIPOPOLYSACCHARIDE-INDUCED MODEL OF CENTRAL NERVOUS SYSTEM INFLAMMATION , 2005, Drug Metabolism and Disposition.
[33] Oliver Hankinson,et al. Role of Mediator in Transcriptional Activation by the Aryl Hydrocarbon Receptor* , 2004, Journal of Biological Chemistry.
[34] C. Galanos,et al. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice , 1987, The Journal of experimental medicine.
[35] C. Xiao,et al. NF-κB, an Evolutionarily Conserved Mediator of Immune and Inflammatory Responses , 2005 .
[36] K. Renton. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. , 2004, Current drug metabolism.